28 Feb 2011
Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis (Alternext: ALCLS), has today launched TALEN AccessTM , the first fee-for-service custom...
Copyright 2012 Cellectis
Design & Development by EtonDigital